drug coming off patent

business acumen
Neue Antwort am 30. Aug. 2021
3 Antworten
949 Views
Anonym A fragte am 28. Aug. 2021

what is the impact of patent expiring for a drug in the context of a case interview? Competitors may launch generic, so would this only impact potential revenues we cant get post expiry?

Übersicht der Antworten

Upvotes
  • Upvotes
  • Datum aufsteigend
  • Datum absteigend
Beste Antwort
Slawomir
Experte
antwortete am 29. Aug. 2021
Former McK interviewer, PhD who successfully transitioned from Academia, received offers from McK/BCG/Bain/LEK

Certainly, increased competition can lead to revenue decrease. Therefore, I would suggest thinking more broadly about the strategic response (e.g., obtaining approval for different diseases, considering other markets with longer protection, adjusting marketing to target specific groups, pricing review, securing the supply of API - increased demand with limited supply may lead to cost inflation). It is not a MECE list but you can start building an appropriate framework based on these examples.

War diese Antwort hilfreich?
Anonym A am 7. Nov. 2021

can you apply for a patent in a different region? And sell it at a monopolistic price there? Thought if it comes off a patent, it was the same situation globally? Good to know if this isn't the case

Ian
Experte
Content Creator
antwortete am 29. Aug. 2021
#1 BCG coach | MBB | Tier 2 | Digital, Tech, Platinion | 100% personal success rate (8/8) | 95% candidate success rate

Hi there,

It depends on the case prompt + objective here. Can you provide more detail?

In essence however, when a drug comes off a patent, that means it no longer has monopoly power. Generics can come in and sell for a far lower price.

There is a huge impact here in terms of both volumes and price.

One way we can compete is by leveraging brand awareness (like Aspirin and Claritin did).

War diese Antwort hilfreich?
Agrim
Experte
Content Creator
antwortete am 30. Aug. 2021
BCG Dubai Project Leader | Learn to think like a Consultant | Free personalised prep plan | 6+ years in Consulting

Drug comes-off the patent → other companies make generics and sell it at cheap price since they don't have any R&D cost to amortise → original company can't sell at the same monopolistic price any more → plus the market becomes fragmented because the suppliers become many

It impacts mainly post-expiry revenue. Plus you need to factor-in the fact that post-expiry lowered revenues may not be enough to pay-off the amortised R&D cost so you might have to amortise it while the patent is in effect. Companies can try to get extensions, file other patents for other medicines, etc. etc.

War diese Antwort hilfreich?
Slawomir gab die beste Antwort

Slawomir

CoachingPlus-Experten
Premium + Coaching-Experten
Former McK interviewer, PhD who successfully transitioned from Academia, received offers from McK/BCG/Bain/LEK
8
Meetings
301
Q&A Upvotes
0
Awards
4,5
2 Bewertungen
Wie wahrscheinlich ist es, dass du uns einem Freund oder Kommilitonen empfiehlst?
0
1
2
3
4
5
6
7
8
9
10
0 = Nicht wahrscheinlich
10 = Sehr wahrscheinlich